sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
uaaauuugccucaguucauucaa | 578 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uaaauuugccucaguucauucaa | 948 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uaaauuugccucaguucauucaa | 1704 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uaaauuugccucaguucauucaa | 1342 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
agagccaaaaucaagauuu | 77 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugccuuuuaaauuugccucag | 1711 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugccuuuuaaauuugccucag | 988 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugccuuuuaaauuugccucag | 618 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugccuuuuaaauuugccucag | 1349 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auagagaaauuucuguggg | 114 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acaauuaagcuccuucuuuuu | 265 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acaauuaagcuccuucuuuuu | 635 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acaauuaagcuccuucuuuuu | 1376 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acaauuaagcuccuucuuuuu | 1014 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauggacaaagucuuuaagacca | 1198 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauggacaaagucuuuaagacca | 1560 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauggacaaagucuuuaagacca | 989 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauggacaaagucuuuaagacca | 619 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaauuaaugacauauuucaaa | 1040 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaauuaaugacauauuucaaa | 352 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaauuaaugacauauuucaaa | 722 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaauuaaugacauauuucaaa | 1402 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuauuugacuaugcuguug | 129 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uggaucaacauuuugguug | 105 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ccauagugaagcaaucuaauu | 278 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ccauagugaagcaaucuaauu | 1127 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ccauagugaagcaaucuaauu | 1489 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ccauagugaagcaaucuaauu | 648 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aauaugucauuaauuuggc | 128 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuauauguaguucuucucaguuc | 1200 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuauauguaguucuucucaguuc | 845 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuauauguaguucuucucaguuc | 1562 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuauauguaguucuucucaguuc | 475 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gcaaucccggaaaacaaagau | 1497 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gcaaucccggaaaacaaagau | 806 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gcaaucccggaaaacaaagau | 436 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gcaaucccggaaaacaaagau | 1135 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaaagacugaucaaauauguug | 1210 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaaagacugaucaaauauguug | 1572 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaaagacugaucaaauauguug | 472 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaaagacugaucaaauauguug | 842 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauuuguaguucucccacguuuc | 560 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauuuguaguucucccacguuuc | 930 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauuuguaguucucccacguuuc | 1657 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauuuguaguucucccacguuuc | 1295 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aacuugagaguugcugggucuga | 593 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aacuugagaguugcugggucuga | 963 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aacuugagaguugcugggucuga | 1276 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aacuugagaguugcugggucuga | 1638 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugaaguuuugugauccaucua | 864 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugaaguuuugugauccaucua | 1278 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugaaguuuugugauccaucua | 494 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugaaguuuugugauccaucua | 1640 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuuuaaauuugccucaguucau | 1726 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuuuaaauuugccucaguucau | 592 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuuuaaauuugccucaguucau | 1364 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuuuaaauuugccucaguucau | 962 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auaguugguuucgugauuuccca | 487 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auaguugguuucgugauuuccca | 1292 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auaguugguuucgugauuuccca | 1654 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auaguugguuucgugauuuccca | 857 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuugcuuugugaucccaaguag | 1696 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuugcuuugugaucccaaguag | 514 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuugcuuugugaucccaaguag | 884 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuugcuuugugaucccaaguag | 1334 | US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,221,213 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aggguaucaagacuacgaaccug | 205 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aggguaucaagacuacgaaccug | 205 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aggguaucaagacuacgaaccug | 655 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aggguaucaagacuacgaaccug | 655 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugagcaugagacuaugcaccuau | 1182 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugagcaugagacuaugcaccuau | 1182 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacgacagugugguguaaaggaa | 2537 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gacgacagugugguguaaaggaa | 2537 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggaagaaacacuuuaaaggag | 2372 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggaagaaacacuuuaaaggag | 2372 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggaagaaacacuuuaaaggag | 3437 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugggaagaaacacuuuaaaggag | 3437 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gagaagaccaaagagcaagugac | 2552 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gagaagaccaaagagcaagugac | 2552 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gagaagaccaaagagcaagugac | 2770 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
gagaagaccaaagagcaagugac | 2770 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
augagacuaugcaccuauaaaua | 1185 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
augagacuaugcaccuauaaaua | 1185 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugaggcuuaugaaaugccuucag | 1155 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
ugaggcuuaugaaaugccuucag | 1155 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucuccuuuaaaguguuucuucc | 2725 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uucuccuuuaaaguguuucuucc | 2725 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacaguucagagugcacuua | 366 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacaguucagagugcacuua | 366 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacaguucagagugcacuua | 96 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacaguucagagugcacuua | 96 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacaguucagagugcacuua | 546 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacaguucagagugcacuua | 546 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacaguucagagugcacuua | 816 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
aaacaguucagagugcacuua | 816 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uugcucccaguuucuugagaucu | 663 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uugcucccaguuucuugagaucu | 663 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uugcucccaguuucuugagaucu | 213 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
uugcucccaguuucuugagaucu | 213 | MX2023003810A | COMPOSICIONES DE ARN DE INTERFERENCIA (ARNI) DE ALFA SINUCLEINA (SNCA) Y METODOS DE USOS DE LAS MISMAS PARA TRATAR O PREVENIR ENFERMEDADES NEURODEGENERATIVAS ASOCIADAS CON LA SNCA | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
agaaguuguuagugauuugcuau | 689 | MX2023003810A | SNCA irna compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases. | 20,230,612 | 1 | [
"CN",
"HK",
"JP",
"IN",
"SG",
"IL",
"TW",
"KR",
"US",
"EA",
"BR",
"MX",
"EP",
"CA",
"ZA",
"WO",
"NZ",
"AU",
"AR"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.